X-23783398-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_002970.4(SAT1):c.47A>T(p.Asp16Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002970.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAT1 | NM_002970.4 | c.47A>T | p.Asp16Val | missense_variant | Exon 1 of 6 | ENST00000379270.5 | NP_002961.1 | |
SAT1 | NR_027783.3 | n.226A>T | non_coding_transcript_exon_variant | Exon 1 of 7 | ||||
LOC127933115 | NM_001414725.1 | c.*31A>T | downstream_gene_variant | NP_001401654.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SAT1 | ENST00000379270.5 | c.47A>T | p.Asp16Val | missense_variant | Exon 1 of 6 | 1 | NM_002970.4 | ENSP00000368572.4 | ||
ENSG00000288706 | ENST00000683890.1 | c.*31A>T | downstream_gene_variant | ENSP00000506989.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.47A>T (p.D16V) alteration is located in exon 1 (coding exon 1) of the SAT1 gene. This alteration results from a A to T substitution at nucleotide position 47, causing the aspartic acid (D) at amino acid position 16 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.